
Rosfion
Rosfion is indicated for :
Patients with primary hypercholesterolaemia (type lla, including heterozygous familial hypercholesterolaemia) or mixed dyslipidemia (type llb) as an adjunct to diet when response to diet and exercise is inadequate.
Reduces elevated LDL-cholesterol, total cholesterol, triglycerides and ApoB, and increases HDL-cholesterol
Patients with homozygous familial hypercholesterolaemia as an adjunct to diet and other lipid lowering treatments (e.g. LDL apheresis)
Short Description
Rosfion with active ingredient Rosuvastatin calcium (equivalent with Rosuvastatin) is available in 20 mg film coated tablet
Indications
Rosfion is indicated for :
Patients with primary hypercholesterolaemia (type lla, including heterozygous familial hypercholesterolaemia) or mixed dyslipidemia (type llb) as an adjunct to diet when response to diet and exercise is inadequate.
Reduces elevated LDL-cholesterol, total cholesterol, triglycerides and ApoB, and increases HDL-cholesterol
Patients with homozygous familial hypercholesterolaemia as an adjunct to diet and other lipid lowering treatments (e.g. LDL apheresis)
Specification
Oral
Rosfion Film Coated Tablet 20 mg
Box, 3 blisters @ 10 film coated tablets
